ArticleLeukemia2025

Targeting HDAC8 sensitizes tyrosine kinase inhibitors in the elimination of B-cell acute lymphoblastic leukemia cells through degradation of HIF-1α.

Guilin Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.